While SOLIUS is not indicated for treating psoriasis and we have not done studies to allow us to make a recommendation for the condition, studies have shown that UVB phototherapy and increasing levels of vitamin D can be used as effective treatments for some skin conditions. Clinicians have used UVB phototherapy for decades to successfully and safely treat psoriasis.
The UVB spectrum emitted by SOLIUS (293 – 303nm) has been shown to maximize previtamin D, having systemic hormonal and immune system impact. Psoriasis is caused by immune system dysfunction and key mechanisms of immune responses are mediated by vitamin D. Many researchers suggest that cutaneous synthesis of vitamin D (such as through SOLIUS) is a major contributing factor to UVB phototherapy efficacy.
Additionally, we know of many instances where natural production of vitamin D is a better option than an oral supplement. Many individuals cannot absorb oral vitamin D through their digestive tract effectively, and even if you can, synthetic supplements may not contain the amount of vitamin D that they claim. Vitamin D from oral supplementation bypasses the body’s built-in feedback mechanisms which provide protection against toxicity. You don’t have to worry about any of this with SOLIUS.
We recommend that you consult with your dermatologist prior to using SOLIUS to discuss if light therapy will be an effective treatment for your condition. You should also ask your dermatologist how frequently you would need to receive light therapy for this method to be effective. SOLIUS can be used once every 5 days.